➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Moodys
Harvard Business School
Colorcon
Express Scripts

Last Updated: July 29, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206276


Email this page to a colleague

« Back to Dashboard

NDA 206276 describes PATADAY ONCE DAILY RELIEF, which is a drug marketed by Alcon Labs Inc and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug. Additional details are available on the PATADAY ONCE DAILY RELIEF profile page.

The generic ingredient in PATADAY ONCE DAILY RELIEF is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 206276
Tradename:PATADAY ONCE DAILY RELIEF
Applicant:Alcon Labs Inc
Ingredient:olopatadine hydrochloride
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 206276
Suppliers and Packaging for NDA: 206276
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PATADAY ONCE DAILY RELIEF olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 206276 NDA Alcon Laboratories, Inc. 0065-0816 0065-0816-01 2 BOTTLE, PLASTIC in 1 CARTON (0065-0816-01) > 2.5 mL in 1 BOTTLE, PLASTIC
PATADAY ONCE DAILY RELIEF olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 206276 NDA Alcon Laboratories, Inc. 0065-0816 0065-0816-02 1 BOTTLE, PLASTIC in 1 CARTON (0065-0816-02) > .5 mL in 1 BOTTLE, PLASTIC
Paragraph IV (Patent) Challenges for 206276
Tradename Dosage Ingredient NDA Submissiondate
PATADAY ONCE DAILY RELIEF SOLUTION/DROPS;OPHTHALMIC olopatadine hydrochloride 206276 2015-09-10

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.7% BASE
Approval Date:Jan 30, 2015TE:RLD:Yes
Patent:⤷  Try it FreePatent Expiration:May 19, 2032Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF OCULAR ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS
Patent:⤷  Try it FreePatent Expiration:May 19, 2032Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Medtronic
McKinsey
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.